<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01812044</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00033000</org_study_id>
    <nct_id>NCT01812044</nct_id>
  </id_info>
  <brief_title>Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery</brief_title>
  <official_title>Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if local anesthetic, either a subtenons injection
      (an injection just beneath the surface tissue of the eye) or a topical ophthalmic gel
      (applied directly on the surface of the eye) given at the end of strabismus surgery reduces
      postoperative pain. Some surgeons routinely use either the subtenon and/or topical anesthetic
      for pain at the end of strabismus surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average Pain Score Over the First 30 Post-operative Minutes Using the CHEOPS Scale</measure>
    <time_frame>0-30 minutes post-operative</time_frame>
    <description>Pain will be assessed by a masked observer using the Children's Hospital Eastern Ontario Pain Scale (CHEOPS) scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
Pain is rated every 5 minutes for the first 30 minutes postoperatively. Each pain score collected in the first 30 minutes was averaged to calculate a per per participant average pain score over the first 30 minutes . Then each participant's per participant average pain score was combined to calculate the reported mean for &quot;Average pain score over the first 30 post-operative minutes using the CHEOPS scale.&quot; for each group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak Pain Score</measure>
    <time_frame>0-150 minutes post-operative</time_frame>
    <description>This secondary outcome will include the peak pain score for duration of follow up period. Pain will be assessed by masked observers, using the CHEOPS scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
A pain score was assessed and recorded every 5 minutes by a masked observer (clinical research coordinator) for the first 30 minutes after extubation, then every 15 minutes for the next hour, then, if applicable, hourly until discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Narcotic Use During Post-operative Recovery</measure>
    <time_frame>Total time in post-operative recovery - up to 6 hours</time_frame>
    <description>This secondary outcome will include total narcotic use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative Postoperative Behavior Score on the PHBQ (Post Hospitalization Behavioral Questionnaire)</measure>
    <time_frame>1 week (+/- 3 days) post operatively</time_frame>
    <description>This secondary outcome will determine the negative postoperative behaviors based on the PHBQ questionnaire given to the parents of the child 1 week (+/- 3 days) post-operatively.
with a score of 81 indicating no change, a score of less than 81 indicating a change for the better, and a score of over 81 indicating a change for the worse, on average, in behavior.
Lowest score 27; highest score 135</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Time to Discharge</measure>
    <time_frame>0-150 minutes post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Post Operative Nausea and Vomiting</measure>
    <time_frame>0-150 minutes post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Required Anti-emetic Medication Post-operatively</measure>
    <time_frame>Total time in post-operative recovery - up to 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Pain Score During First 30 Minutes</measure>
    <time_frame>0-30 minutes post-operative</time_frame>
    <description>This secondary outcome will include the peak pain score for duration of follow up period. Pain will be assessed by masked observers, using the CHEOPS scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
Pain is rated every 5 minutes for the first 30 minutes postoperatively.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Strabismus</condition>
  <arm_group>
    <arm_group_label>subtenons anesthetic and topical control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>topical anesthetic and subtenons control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>topical control and subtenons control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>subtenons anesthetic - preservative-free bupivacaine 0.75%</intervention_name>
    <arm_group_label>subtenons anesthetic and topical control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel</intervention_name>
    <arm_group_label>topical anesthetic and subtenons control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topical control - 0.5 cc of Hypromellose 0.3% gel</intervention_name>
    <arm_group_label>subtenons anesthetic and topical control</arm_group_label>
    <arm_group_label>topical control and subtenons control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>subtenons control - 0.5 cc of Normal Saline</intervention_name>
    <arm_group_label>topical anesthetic and subtenons control</arm_group_label>
    <arm_group_label>topical control and subtenons control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 1 year to &lt; 8 years

          -  Undergoing strabismus surgery under general anesthesia

          -  No previous surgery on muscle to be operated

          -  No known allergy to lidocaine or bupivacaine

          -  Investigator willing to inject subtenons NS or preservative-free bupivacaine 0.75% by
             cannula into all surgical wounds and willing to administer topical lidocaine 3.5%
             ophthalmic gel or Hypromellose 0.3% gel (GenTeal Severe Dry Eye Relief) to all
             surgical wounds at the end of strabismus surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Enyedi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Eye Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke Eye Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2013</study_first_submitted>
  <study_first_submitted_qc>March 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2013</study_first_posted>
  <results_first_submitted>December 1, 2015</results_first_submitted>
  <results_first_submitted_qc>March 24, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 26, 2016</results_first_posted>
  <last_update_submitted>March 24, 2016</last_update_submitted>
  <last_update_submitted_qc>March 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Strabismus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>57 participants signed consent. 7 participants were withdrawn by PI prior to randomization.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Subtenons Anesthetic and Topical Control</title>
          <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
        </group>
        <group group_id="P2">
          <title>Topical Anesthetic and Subtenons Control</title>
          <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
        </group>
        <group group_id="P3">
          <title>Topical Control and Subtenons Control</title>
          <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Subtenons Anesthetic and Topical Control</title>
          <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
        </group>
        <group group_id="B2">
          <title>Topical Anesthetic and Subtenons Control</title>
          <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
        </group>
        <group group_id="B3">
          <title>Topical Control and Subtenons Control</title>
          <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="16"/>
            <count group_id="B4" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.6" lower_limit="13" upper_limit="87"/>
                    <measurement group_id="B2" value="50.1" lower_limit="19" upper_limit="91"/>
                    <measurement group_id="B3" value="60.9" lower_limit="27" upper_limit="89"/>
                    <measurement group_id="B4" value="54.9" lower_limit="13" upper_limit="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Average Pain Score Over the First 30 Post-operative Minutes Using the CHEOPS Scale</title>
        <description>Pain will be assessed by a masked observer using the Children's Hospital Eastern Ontario Pain Scale (CHEOPS) scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
Pain is rated every 5 minutes for the first 30 minutes postoperatively. Each pain score collected in the first 30 minutes was averaged to calculate a per per participant average pain score over the first 30 minutes . Then each participant's per participant average pain score was combined to calculate the reported mean for “Average pain score over the first 30 post-operative minutes using the CHEOPS scale.” for each group.</description>
        <time_frame>0-30 minutes post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Average Pain Score Over the First 30 Post-operative Minutes Using the CHEOPS Scale</title>
          <description>Pain will be assessed by a masked observer using the Children's Hospital Eastern Ontario Pain Scale (CHEOPS) scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
Pain is rated every 5 minutes for the first 30 minutes postoperatively. Each pain score collected in the first 30 minutes was averaged to calculate a per per participant average pain score over the first 30 minutes . Then each participant's per participant average pain score was combined to calculate the reported mean for “Average pain score over the first 30 post-operative minutes using the CHEOPS scale.” for each group.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.36" spread="0.97"/>
                    <measurement group_id="O2" value="6.57" spread="1.06"/>
                    <measurement group_id="O3" value="6.58" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Pain Score</title>
        <description>This secondary outcome will include the peak pain score for duration of follow up period. Pain will be assessed by masked observers, using the CHEOPS scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
A pain score was assessed and recorded every 5 minutes by a masked observer (clinical research coordinator) for the first 30 minutes after extubation, then every 15 minutes for the next hour, then, if applicable, hourly until discharge.</description>
        <time_frame>0-150 minutes post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Pain Score</title>
          <description>This secondary outcome will include the peak pain score for duration of follow up period. Pain will be assessed by masked observers, using the CHEOPS scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
A pain score was assessed and recorded every 5 minutes by a masked observer (clinical research coordinator) for the first 30 minutes after extubation, then every 15 minutes for the next hour, then, if applicable, hourly until discharge.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.65" spread="2.42"/>
                    <measurement group_id="O2" value="10.47" spread="2.27"/>
                    <measurement group_id="O3" value="9.69" spread="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.035</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>P-value based on Wilcoxon rank sum test of difference in medians between groups.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.189</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>P-value based on Wilcoxon rank sum test of difference in medians between groups.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.298</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>P-value based on Wilcoxon rank sum test of difference in medians between groups.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Narcotic Use During Post-operative Recovery</title>
        <description>This secondary outcome will include total narcotic use</description>
        <time_frame>Total time in post-operative recovery - up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Total Narcotic Use During Post-operative Recovery</title>
          <description>This secondary outcome will include total narcotic use</description>
          <units>mcg/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.65" spread="0.61"/>
                    <measurement group_id="O2" value="1.78" spread="0.66"/>
                    <measurement group_id="O3" value="1.60" spread=".077"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Negative Postoperative Behavior Score on the PHBQ (Post Hospitalization Behavioral Questionnaire)</title>
        <description>This secondary outcome will determine the negative postoperative behaviors based on the PHBQ questionnaire given to the parents of the child 1 week (+/- 3 days) post-operatively.
with a score of 81 indicating no change, a score of less than 81 indicating a change for the better, and a score of over 81 indicating a change for the worse, on average, in behavior.
Lowest score 27; highest score 135</description>
        <time_frame>1 week (+/- 3 days) post operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Negative Postoperative Behavior Score on the PHBQ (Post Hospitalization Behavioral Questionnaire)</title>
          <description>This secondary outcome will determine the negative postoperative behaviors based on the PHBQ questionnaire given to the parents of the child 1 week (+/- 3 days) post-operatively.
with a score of 81 indicating no change, a score of less than 81 indicating a change for the better, and a score of over 81 indicating a change for the worse, on average, in behavior.
Lowest score 27; highest score 135</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.2" spread="7.8"/>
                    <measurement group_id="O2" value="78.2" spread="10.9"/>
                    <measurement group_id="O3" value="78.5" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Time to Discharge</title>
        <time_frame>0-150 minutes post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Average Time to Discharge</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106" spread="16"/>
                    <measurement group_id="O2" value="107" spread="25"/>
                    <measurement group_id="O3" value="106" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Post Operative Nausea and Vomiting</title>
        <time_frame>0-150 minutes post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Post Operative Nausea and Vomiting</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Required Anti-emetic Medication Post-operatively</title>
        <time_frame>Total time in post-operative recovery - up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Required Anti-emetic Medication Post-operatively</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Pain Score During First 30 Minutes</title>
        <description>This secondary outcome will include the peak pain score for duration of follow up period. Pain will be assessed by masked observers, using the CHEOPS scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
Pain is rated every 5 minutes for the first 30 minutes postoperatively.</description>
        <time_frame>0-30 minutes post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subtenons Anesthetic and Topical Control</title>
            <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
          </group>
          <group group_id="O2">
            <title>Topical Anesthetic and Subtenons Control</title>
            <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
          <group group_id="O3">
            <title>Topical Control and Subtenons Control</title>
            <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Pain Score During First 30 Minutes</title>
          <description>This secondary outcome will include the peak pain score for duration of follow up period. Pain will be assessed by masked observers, using the CHEOPS scale. The CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) is a behavioral scale for evaluating postoperative pain in young children. The scale is assessed using the sum of a score for cry (1-3), facial expression (0-2), verbalization (0-2), torso (1-2), touch (1-2) and legs (1-2). The minimum score is 4, the maximum score is 13, and higher scores indicate more pain.
Pain is rated every 5 minutes for the first 30 minutes postoperatively.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" spread="1.9"/>
                    <measurement group_id="O2" value="7.8" spread="2.4"/>
                    <measurement group_id="O3" value="8.3" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Subtenons Anesthetic and Topical Control</title>
          <description>Group 1 (subtenons anesthetic and topical control): 0.5 cc of local anesthetic (preservative-free bupivacaine 0.75%) administered via a cannula subtenons through each surgical wound with 0.5 cc of Hypromellose 0.3% gel applied topically to each surgical wound at end of surgery
subtenons anesthetic - preservative-free bupivacaine 0.75%
topical control - 0.5 cc of Hypromellose 0.3% gel</description>
        </group>
        <group group_id="E2">
          <title>Topical Anesthetic and Subtenons Control</title>
          <description>Group 2 (topical anesthetic and subtenons control): 0.5 cc of lidocaine 3.5% ophthalmic gel applied topically to each surgical wound and 0.5 cc of normal saline (NS) administered via a cannula subtenons through each surgical wound at end of surgery
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel
subtenons control - 0.5 cc of Normal Saline</description>
        </group>
        <group group_id="E3">
          <title>Topical Control and Subtenons Control</title>
          <description>Group 3 (topical control and subtenons control): 0.5 cc of topical Hypromellose 0.3% gel applied topically to each surgical wound and 0.5 cc of NS administered via a cannula subtenons through each surgical wound at end of surgery
topical control - 0.5 cc of Hypromellose 0.3% gel
subtenons control - 0.5 cc of Normal Saline</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Laura Enyedi, M.D.</name_or_title>
      <organization>Duke University Medical Center</organization>
      <phone>919-684-2038</phone>
      <email>laura.enyedi@dm.duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

